Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Effects of prenatal perfluoroalkyl acid exposure on cord blood IGF2/H19 methylation and ponderal index: The Hokkaido Study

Abstract

Prenatal exposure to perfluoroalkyl acids (PFAAs) influences fetal growth and long-term health. However, whether PFAAs affect offspring DNA methylation patterns to influence health outcomes is yet to be evaluated. Here, we assessed effect of prenatal PFAA exposure on cord blood insulin-like growth factor 2 (IGF2), H19, and long interspersed element 1 (LINE1) methylation and its associations with birth size. Mother–child pairs (N=177) from the Hokkaido Study on Environment and Children’s Health were included in the study. Perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) levels in maternal serum were measured by liquid chromatography-tandem mass spectrometry. IGF2, H19, and LINE1 methylation in cord blood DNA was determined by pyrosequencing. After full adjustment in multiple linear regression models, IGF2 methylation showed a significant negative association with log-unit increase in PFOA (partial regression coefficient=−0.73; 95% confidence interval: −1.44 to −0.02). Mediation analysis suggested that reduced IGF2 methylation explained ~21% of the observed association between PFOA exposure and reduced ponderal index of the infant at birth. These results indicated that the effects of prenatal PFOA exposure could be mediated through DNA methylation. Further study will be required to determine the potential for long-term adverse health effects of reduced IGF2 methylation induced by PFOA exposure.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. United Nations Environment Programme. POPRC3: Development of Risk Management Evaluation, 2007. Available at: http://chm.pops.int/Portals/0/Repository/poprc3/UNEP-POPS-POPRC.3-POPRC-3-5.English.PDF (date last accessed 16 January 2016).

  2. Olsen GW, Lange CC, Ellefson ME, Mair DC, Church TR, Goldberg CL et al. Temporal trends of perfluoroalkyl concentrations in American Red Cross adult blood donors, 2000–2010. Environ Sci Technol 2012; 5: 6330–6338.

    Article  Google Scholar 

  3. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J . Perfluoroalkyl acids: A review of monitoring and toxicological findings. Toxicol Sci 2007; 99: 366–394.

    Article  CAS  Google Scholar 

  4. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 2007; 115: 1298–1305.

    Article  CAS  Google Scholar 

  5. Inoue K, Okada F, Ito R, Kato S, Sasaki S, Nakajima S et al. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: Assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 2004; 112: 1204–1207.

    Article  CAS  Google Scholar 

  6. Midasch O, Drexler H, Hart N, Beckmann MW, Angerer J . Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: A pilot study. Int Arch Occup Environ Health 2007; 80: 643–648.

    Article  CAS  Google Scholar 

  7. Olsen GW, Butenhoff JL, Zobel LR . Perfluoroalkyl chemicals and human fetal development: An epidemiologic review with clinical and toxicological perspectives. Repr Toxicol 2009; 27: 212–230.

    Article  CAS  Google Scholar 

  8. Verner MA, Loccisano AE, Morken NH, Yoon M, Wu H, McDougall R et al. Associations of perfluoroalkyl substances (PFAS) with lower birth weight: An evaluation of potential confounding by glomerular filtration rate using a physiologically based pharmacokinetic model (PBPK). Environ Health Perspect 2015; 123: 1317–1324.

    Article  CAS  Google Scholar 

  9. Washino N, Saijo Y, Sasaki S, Kato S, Ban S, Konishi K et al. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ Health Perspect 2009; 117: 660–667.

    Article  CAS  Google Scholar 

  10. Kishi R, Nakajima T, Goudarzi H, Kobayashi S, Sasaki S, Okada E et al. The association of prenatal exposure to perfluorinated chemicals with maternal essential and long-chain polyunsaturated fatty acids during pregnancy and the birth weight of their offspring: The Hokkaido study. Environ Health Perspect 2015; 123: 1038–1045.

    Article  CAS  Google Scholar 

  11. Kato S, Itoh S, Yuasa M, Baba T, Miyashita C, Sasaki S et al. Association of perfluorinated chemical exposure in utero with maternal and infant thyroid hormone levels in the Sapporo cohort of Hokkaido study on the environment and children’s health. Environ Health Prev Med 2016 (e-pub ahead of print 30 April 2016).

  12. Itoh S, Araki A, Mitsui T, Miyashita C, Goudarzi H, Sasaki S et al. Association of perfluoroalkyl substances exposure in utero with reproductive hormone levels in cord blood in the Hokkaido Study on Environment and Children’s Health. Environ Int 2016; 94: 51–59.

    Article  CAS  Google Scholar 

  13. Hackett JA, Surani MA . DNA methylation dynamics during the mammalian life cycle. Philos Trans R Soc Lond Ser B 2013; 368: 20110328.

    Article  Google Scholar 

  14. Drong AW, Lindgren CM, McCarthy MI . The genetic and epigenetic basis of type 2 diabetes and obesity. Clin Pharmacol Ther 2012; 92: 707–715.

    Article  CAS  Google Scholar 

  15. Green BB, Marsit CJ . Select prenatal environmental exposures and subsequent alterations of gene-specific and repetitive element DNA methylation in fetal tissues. Curr Environ Health Rep 2015; 2: 126–136.

    Article  CAS  Google Scholar 

  16. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E et al. Analysis of repetitive element DNA methylation by methylight. Nucleic Acids Res 2005; 33: 6823–6836.

    Article  CAS  Google Scholar 

  17. Gabory A, Jammes H, Dandolo L . The H19 locus: Role of an imprinted non-coding RNA in growth and development. BioEssays 2010; 32: 473–480.

    Article  CAS  Google Scholar 

  18. Bouwland-Both MI, van Mil NH, Stolk L, Eilers PH, Verbiest MM, Heijmans BT et al. DNA methylation of IGF2DMR and H19 is associated with fetal and infant growth: The generation R study. PLoS One 2013; 8: e81731.

    Article  Google Scholar 

  19. St-Pierre J, Hivert MF, Perron P, Poirier P, Guay SP, Brisson D et al. IGF2 DNA methylation is a modulator of newborn’s fetal growth and development. Epigenetics 2012; 7: 1125–1132.

    Article  CAS  Google Scholar 

  20. Cianfarani S . Insulin-like growth factor-II: New roles for an old actor. Front Endocrinol 2012; 3: 118.

    Google Scholar 

  21. Perkins E, Murphy SK, Murtha AP, Schildkraut J, Jirtle RL, Demark-Wahnefried W et al. Insulin-like growth factor 2/H19 methylation at birth and risk of overweight and obesity in children. J Pediatr 2012; 161: 31–39.

    Article  CAS  Google Scholar 

  22. Guerrero-Preston R, Goldman LR, Brebi-Mieville P, Ili-Gangas C, LeBron C, Witter FR et al. Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds. Epigenetics 2010; 5: 539–546.

    Article  CAS  Google Scholar 

  23. Kishi R, Kobayashi S, Ikeno T, Araki A, Miyashita C, Itoh S et al. Ten years of progress in the Hokkaido birth cohort study on environment and children’s health: Cohort profile—updated 2013. Environ Health Prev Med 2013 18: 429–450.

  24. Kishi R, Sasaki S, Yoshioka E, Yuasa M, Sata F, Saijo Y et al. Cohort profile: the Hokkaido study on environment and children’s health in Japan. Int J Epidemiol 2011; 40: 611–618.

    Article  Google Scholar 

  25. Nakata A, Saito K, Iwasaki Y, Ito R, Kishi R, Nakazawa H . Determination of perfluorinated compounds in human milk and evaluation of their transition from maternal plasma. Bunseki Kagaku 2009; 58: 653–659.

    Article  CAS  Google Scholar 

  26. Uh HW, Hartgers FC, Yazdanbakhsh M, Houwing-Duistermaat JJ . Evaluation of regression methods when immunological measurements are constrained by detection limits. BMC Immunol 2008; 9: 59.

    Article  Google Scholar 

  27. Lubin JH, Colt JS, Camann D, Davis S, Cerhan JR, Severson RK et al. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect 2004; 112: 1691–1696.

    Article  CAS  Google Scholar 

  28. Murphy SK, Adigun A, Huang Z, Overcash F, Wang F, Jirtle RL et al. Gender-specific methylation differences in relation to prenatal exposure to cigarette smoke. Gene 2012; 494: 36–43.

    Article  CAS  Google Scholar 

  29. Bollati V, Baccarelli A, Hou L, Bonzini M, Fustinoni S, Cavallo D et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res 2007; 67: 876–880.

    Article  CAS  Google Scholar 

  30. Miller HC, Hassanein K . Diagnosis of impaired fetal growth in newborn infants. Pediatrics 1971; 48: 511–522.

    CAS  PubMed  Google Scholar 

  31. Textor J, Hardt J, Knuppel S . DAGitty: a graphical tool for analyzing causal diagrams. Epidemiology 2011; 22: 745.

    Article  Google Scholar 

  32. Goudarzi H, Nakajima S, Ikeno T, Sasaki S, Kobayashi S, Miyashita C et al. Prenatal exposure to perfluorinated chemicals and neurodevelopment in early infancy: the Hokkaido study. Sci Total Environ 2016; 541: 1002–1010.

    Article  CAS  Google Scholar 

  33. Hayes AF . Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach. Guilford Press: New York, NY, USA. 2013.

    Google Scholar 

  34. Preacher KJ, Hayes AF . Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008; 40: 879–891.

    Article  Google Scholar 

  35. Fairchild AJ, Mackinnon DP, Taborga MP, Taylor AB . R2 effect-size measures for mediation analysis. Behav Res Methods 2009; 41: 486–498.

    Article  Google Scholar 

  36. Richiardi L, Bellocco R, Zugna D . Mediation analysis in epidemiology: methods, interpretation and bias. Int J Epidemiol 2013; 42: 1511–1519.

    Article  Google Scholar 

  37. Watkins DJ, Wellenius GA, Butler RA, Bartell SM, Fletcher T, Kelsey KT . Associations between serum perfluoroalkyl acids and LINE-1 DNA methylation. Environ Int 2014; 63: 71–76.

    Article  CAS  Google Scholar 

  38. Leter G, Consales C, Eleuteri P, Uccelli R, Specht IO, Toft G et al. Exposure to perfluoroalkyl substances and sperm DNA global methylation in Arctic and European populations. Environ Mol Mut 2014; 55: 591–600.

    Article  CAS  Google Scholar 

  39. Apelberg BJ, Witter FR, Herbstman JB, Calafat AM, Halden RU, Needham LL et al. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 2007; 115: 1670–1676.

    Article  CAS  Google Scholar 

  40. Bastos Sales L, Kamstra JH, Cenijn PH, van Rijt LS, Hamers T, Legler J . Effects of endocrine disrupting chemicals on in vitro global DNA methylation and adipocyte differentiation. Toxicol In Vitro 2013; 27: 1634–1643.

    Article  CAS  Google Scholar 

  41. Tian M, Peng S, Martin FL, Zhang J, Liu L, Wang Z et al. Perfluorooctanoic acid induces gene promoter hypermethylation of glutathione-S-transferase Pi in human liver L02 cells. Toxicology 2012; 296: 48–55.

    Article  CAS  Google Scholar 

  42. Hitchler MJ, Domann FE . An epigenetic perspective on the free radical theory of development. Free Radic Biol Med 2007; 43: 1023–1036.

    Article  CAS  Google Scholar 

  43. Wielsoe M, Long M, Ghisari M, Bonefeld-Jorgensen EC . Perfluoroalkylated substances (PFAS) affect oxidative stress biomarkers in vitro. Chemosphere 2015; 129: 239–245.

    Article  Google Scholar 

  44. Hu XZ, Hu DC . Effects of perfluorooctanoate and perfluorooctane sulfonate exposure on hepatoma Hep G2 cells. Arch Toxicol 2009; 83: 851–861.

    Article  CAS  Google Scholar 

  45. Takacs ML, Abbott BD . Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate. Toxicol Sci 2007; 95: 108–117.

    Article  CAS  Google Scholar 

  46. Wakabayashi K, Okamura M, Tsutsumi S, Nishikawa NS, Tanaka T, Sakakibara I et al. The peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha heterodimer targets the histone modification enzyme PR-Set7/Setd8 gene and regulates adipogenesis through a positive feedback loop. Mol Cell Biol 2009; 29: 3544–3555.

    Article  CAS  Google Scholar 

  47. Desvergne B, Feige JN, Casals-Casas C . PPAR-mediated activity of phthalates: a link to the obesity epidemic? Mol Cellular Endrocrinol 2009; 304: 43–48.

    Article  CAS  Google Scholar 

  48. LaRocca J, Binder AM, McElrath TF, Michels KB . The impact of first trimester phthalate and phenol exposure on IGF2/H19 genomic imprinting and birth outcomes. Environ Res 2014; 133: 396–406.

    Article  CAS  Google Scholar 

  49. Beesoon S, Webster GM, Shoeib M, Harner T, Benskin JP, Martin JW . Isomer profiles of perfluorochemicals in matched maternal, cord, and house dust samples: manufacturing sources and transplacental transfer. Environ Health Perspect 2011; 119: 1659–1664.

    Article  CAS  Google Scholar 

  50. Lee YJ, Kim MK, Bae J, Yang JH . Concentrations of perfluoroalkyl compounds in maternal and umbilical cord sera and birth outcomes in Korea. Chemosphere 2013; 90: 1603–1609.

    Article  CAS  Google Scholar 

  51. Vanden Heuvel JP, Thompson JT, Frame SR, Gillies PJ . Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha. Toxicol Sci 2006; 92: 476–489.

    Article  CAS  Google Scholar 

  52. Halldorsson TI, Rytter D, Haug LS, Bech BH, Danielsen I, Becher G et al. Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study. Environ Health Perspect 2012; 120: 668–673.

    Article  CAS  Google Scholar 

  53. Nilsen RM, Vollset SE, Gjessing HK, Skjaerven R, Melve KK, Schreuder P et al. Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr Perinat Epidemiol 2009; 23: 597–608.

    Article  Google Scholar 

  54. Okada E, Kashino I, Matsuura H, Sasaki S, Miyashita C, Yamamoto J et al. Temporal trends of perfluoroalkyl acids in plasma samples of pregnant women in Hokkaido, Japan, 2003–2011. Environ Int 2013; 60: 89–96.

    Article  CAS  Google Scholar 

  55. Buhrke T, Kibellus A, Lampen A . In vitro toxicological characterization of perfluorinated carboxylic acids with different carbon chain lengths. Toxicol Lett 2013; 218: 97–104.

    Article  CAS  Google Scholar 

  56. Wolf CJ, Takacs ML, Schmid JE, Lau C, Abbott BD . Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths. Toxicol Sci 2008; 106: 162–171.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the staff at Sapporo Toho Hospital and the participating mothers and infants for their collaboration. We also thank YM Ito for advice on statistical analyses, TA Yila for advice on epigenetics, and R Ito and Y Iwasaki for PFAA measurements. This study was supported by a Grant-in-Aid for Health Science Research from the Japanese Ministry of Health, Labor and Welfare (No. 717L00204) and by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (Nos. 23390157 and 25253050). We also thank Editage (www.editage.jp) for English language editing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Reiko Kishi.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Journal of Exposure Science and Environmental Epidemiology website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kobayashi, S., Azumi, K., Goudarzi, H. et al. Effects of prenatal perfluoroalkyl acid exposure on cord blood IGF2/H19 methylation and ponderal index: The Hokkaido Study. J Expo Sci Environ Epidemiol 27, 251–259 (2017). https://doi.org/10.1038/jes.2016.50

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jes.2016.50

Keywords

This article is cited by

Search

Quick links